As outlined here by @KirkEvoy, @coreysdavis, & me, the OTC transition should resolve a lot of lingering confusion and constraints in state agencies, community organizations, and healthcare institutions that are distributing / want to distribute Narcan
@StefanKertesz @Country_fiedMD @JSG_54 @ArendtDr @GhanaboyPharmd @XimenaLevander @DrAyanaJordan @AJ_Gordon Explored the topic with @KirkEvoy & @coreysdavis in this commentary. The only valid counterargument I see is potential short-term increase in cos
RT @HillPharmD: 20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opio…
RT @HillPharmD: 20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opio…
RT @HillPharmD: 20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opio…
RT @HillPharmD: 20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opio…
RT @HillPharmD: 20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opio…
20+ years into the deadliest drug crisis in U.S. history & many orgs still struggle to obtain free naloxone from state opioid response funding. Small grants & donations don't cut it at $75/unit. The status quo is unacceptable. We need OTC naloxone
RT @HillPharmD: For more on this topic, check out these two publications from @coreysdavis, @carrderekh, @KirkEvoy, and me. https://t.co/l…
For more on this topic, check out these two publications from @coreysdavis, @carrderekh, @KirkEvoy, and me. https://t.co/lGRG2pzBEw https://t.co/ugoukBdWwN
Read our commentary discussing the need for OTC naloxone in @DovePress open access. https://t.co/U4WNYf4MpQ
@Narcocast @OrianaBeLike @axios See our recent commentary for more info: https://t.co/U0OLKRDVFd
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @noelvest: Would over the counter naloxone save lives? I pray that in 5 years we look back with disgust. https://t.co/29YCi65n6Z
Would over the counter naloxone save lives? I pray that in 5 years we look back with disgust. https://t.co/29YCi65n6Z
RT @coreysdavis: Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with fundin…
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @KirkEvoy: Check out our latest publication which explores successes and shortcomings of current naloxone access laws and makes a case f…
RT @coreysdavis: Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with fundin…
RT @coreysdavis: Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with fundin…
RT @coreysdavis: Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with fundin…
RT @coreysdavis: Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with fundin…
Really enjoyed the opportunity to discuss the rationale for and importance of an OTC naloxone option (combined with funding for widespread distribution) with two pharmacists who really get it, @KirkEvoy and @HillPharmD https://t.co/kMmXjGbXgY
Excellent work Lucas! I agree 100%
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @KirkEvoy: Check out our latest publication which explores successes and shortcomings of current naloxone access laws and makes a case f…
Check out our latest publication which explores successes and shortcomings of current naloxone access laws and makes a case for @US_FDA approval of over-the-counter naloxone. @HillPharmD @coreysdavis https://t.co/dxJfIA6DzB
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
More people die due to opioid overdose in the US than car accidents. This will save lives!
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
OTC #naloxone would help peer-led organisations struggling to navigate complex bureaucratic processes more easily access and distribute naloxone to their communities
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
RT @HillPharmD: Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led comme…
Professional Bucket List: ✅ co-author naloxone paper with @coreysdavis Naloxone should be OTC! In this @KirkEvoy-led commentary, we detail shortcomings of the standing order approach & recommend an OTC switch while addressing potential drawbacks. htt
RT @BroochOpioidEMS: @ERtox @theNNTweet @MDQuincy @ChiRecoveryAlli @CookCountyEM @CookCtyHealth @HillPharmD @KirkEvoy Considering the Poten…
RT @BroochOpioidEMS: @ERtox @theNNTweet @MDQuincy @ChiRecoveryAlli @CookCountyEM @CookCtyHealth @HillPharmD @KirkEvoy Considering the Poten…
@ERtox @theNNTweet @MDQuincy @ChiRecoveryAlli @CookCountyEM @CookCtyHealth @HillPharmD @KirkEvoy Considering the Potential Benefits of Over-the-Counter Naloxone | IPRP @DovePress https://t.co/qGHMUnJKIQ